NEORNAT leverages an AI-driven multi-omics analysis platform to integrate large-scale public datasets (TCGA, GEO) with proprietary RNA data, enabling the discovery of disease-specific biomarkers. Through this approach, we have identified novel diagnostic markers such as GKN1 in gastric cancer. By utilizing predictive models and advanced analytical tools, our platform extends beyond precision diagnostics to the discovery of therapeutic targets.